Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aldo Morrone

Showing results (141-150 of 158) with videos related to

Pageof 16
Sort By:
Journal of Hematology & Oncology|July 30, 2021
Lower response to BNT162b2 vaccine in patients with myelofibrosis compared to polycythemia vera and essential thrombocythemiaFulvia Pimpinelli, Francesco Marchesi, Giulia Piaggio, et al.
Frontiers in Oncology|April 4, 2022
mRNA-COVID19 Vaccination Can Be Considered Safe and Tolerable for Frail PatientsMaria Teresa Lupo-Stanghellini, Serena Di Cosimo, Massimo Costantini, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 9, 2009
Treatment of hepatitis C virus carriers with persistently normal alanine aminotransferase levels with peginterferon alpha-2a and ribavirin: a multicentric studyClaudio Puoti, Adriano M Pellicelli, Mario Romano, et al.
Computational and Structural Biotechnology Journal|January 31, 2022
Evidence of a SARS-CoV-2 double Spike mutation D614G/S939F potentially affecting immune response of infected subjectsSara Donzelli, Francesca Spinella, Enea Gino di Domenico, et al.
Molecular Diagnosis & Therapy|February 22, 2016
Structural and Functional Insights on an Uncharacterized Aγ-Globin-Gene Polymorphism Present in Four β0-Thalassemia Families with High Fetal Hemoglobin LevelsNicoletta Bianchi, Lucia Carmela Cosenza, Ilaria Lampronti, et al.
Frontiers in Immunology|February 13, 2023
Neutralizing antibodies to Omicron after the fourth SARS-CoV-2 mRNA vaccine dose in immunocompromised patients highlight the need of additional boostersMaria Rescigno, Chiara Agrati, Carlo Salvarani, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 17, 2023
Interrogating colorectal cancer metastasis to liver: a search for clinically viable compounds and mechanistic insights in colorectal cancer Patient Derived OrganoidsMario Cioce, Maria Rita Fumagalli, Sara Donzelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2021
Immunogenicity and Safety of COVID-19 Vaccine BNT162b2 for Patients with Solid Cancer: A Large Cohort Prospective Study from a Single InstitutionVincenzo Di Noia, Fulvia Pimpinelli, Davide Renna, et al.
Journal of Clinical Medicine|September 28, 2021
Expression and Clinical Utility of Transcription Factors Involved in Epithelial-Mesenchymal Transition during Thyroid Cancer ProgressionEnke Baldini, Chiara Tuccilli, Daniele Pironi, et al.
Leukemia|September 21, 2021
Impact of anti-CD20 monoclonal antibodies on serologic response to BNT162b2 vaccine in B-cell Non-Hodgkin's lymphomasFrancesco Marchesi, Fulvia Pimpinelli, Diana Giannarelli, et al.
Pageof 16

Showing results (141-150 of 158) with videos related to

Sort By:
Pageof 16
Journal of Hematology & Oncology|July 30, 2021
Lower response to BNT162b2 vaccine in patients with myelofibrosis compared to polycythemia vera and essential thrombocythemiaFulvia Pimpinelli, Francesco Marchesi, Giulia Piaggio, et al.
Frontiers in Oncology|April 4, 2022
mRNA-COVID19 Vaccination Can Be Considered Safe and Tolerable for Frail PatientsMaria Teresa Lupo-Stanghellini, Serena Di Cosimo, Massimo Costantini, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 9, 2009
Treatment of hepatitis C virus carriers with persistently normal alanine aminotransferase levels with peginterferon alpha-2a and ribavirin: a multicentric studyClaudio Puoti, Adriano M Pellicelli, Mario Romano, et al.
Computational and Structural Biotechnology Journal|January 31, 2022
Evidence of a SARS-CoV-2 double Spike mutation D614G/S939F potentially affecting immune response of infected subjectsSara Donzelli, Francesca Spinella, Enea Gino di Domenico, et al.
Molecular Diagnosis & Therapy|February 22, 2016
Structural and Functional Insights on an Uncharacterized Aγ-Globin-Gene Polymorphism Present in Four β0-Thalassemia Families with High Fetal Hemoglobin LevelsNicoletta Bianchi, Lucia Carmela Cosenza, Ilaria Lampronti, et al.
Frontiers in Immunology|February 13, 2023
Neutralizing antibodies to Omicron after the fourth SARS-CoV-2 mRNA vaccine dose in immunocompromised patients highlight the need of additional boostersMaria Rescigno, Chiara Agrati, Carlo Salvarani, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 17, 2023
Interrogating colorectal cancer metastasis to liver: a search for clinically viable compounds and mechanistic insights in colorectal cancer Patient Derived OrganoidsMario Cioce, Maria Rita Fumagalli, Sara Donzelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2021
Immunogenicity and Safety of COVID-19 Vaccine BNT162b2 for Patients with Solid Cancer: A Large Cohort Prospective Study from a Single InstitutionVincenzo Di Noia, Fulvia Pimpinelli, Davide Renna, et al.
Journal of Clinical Medicine|September 28, 2021
Expression and Clinical Utility of Transcription Factors Involved in Epithelial-Mesenchymal Transition during Thyroid Cancer ProgressionEnke Baldini, Chiara Tuccilli, Daniele Pironi, et al.
Leukemia|September 21, 2021
Impact of anti-CD20 monoclonal antibodies on serologic response to BNT162b2 vaccine in B-cell Non-Hodgkin's lymphomasFrancesco Marchesi, Fulvia Pimpinelli, Diana Giannarelli, et al.
Pageof 16